Evidence map›Paper›PMID 42253964›Full record

ArticleFrontiers in immunology2026

Atypical autoimmune hepatitis presenting as acute hepatitis with prominent cholestatic features: a case report.

Xiaomiao Yang, Jingdong Cui, Zhiyuan Xu, Xiaojuan Zheng, Yanfei Zhan, Tingting Lv, Xinyan Zhao, Junjie Ren

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaomiao Yang *Department of Gastroenterology and Hepatology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Jingdong Cui *Department of Gastroenterology and Hepatology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Zhiyuan Xu *Department of Gastroenterology and Hepatology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Xiaojuan ZhengDepartment of Gastroenterology and Hepatology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Yanfei ZhanDepartment of Gastroenterology and Hepatology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Tingting LvDepartment of Liver Research Center, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing, China.
Xinyan ZhaoDepartment of Liver Research Center, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing, China.
Junjie RenDepartment of Gastroenterology and Hepatology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune hepatitis (AIH) poses distinct diagnostic challenges due to its heterogeneous clinical presentation and lack of disease-specific features. This is further complicated by drug-induced liver injury (DILI), which can present with laboratory and histological findings indistinguishable from those of AIH. Here, we report the case of an elderly man who presented with elevated liver enzymes of unclear etiology. Initial laboratory tests showed negative antinuclear antibody (ANA) and normal serum immunoglobulin G (IgG) levels. Based on his history of consuming herbal supplements and a liver biopsy showing acute cholestatic hepatitis with cholangitis lenta, a diagnosis of DILI was initially considered. During a 1-year follow-up, two recurrent episodes of elevated liver enzymes and urine discoloration were observed. Concurrent laboratory tests revealed seroconversion to ANA positivity and an IgG level exceeding 1.2 times the upper limit of normal (ULN). A follow-up liver biopsy demonstrated typical histopathological features of AIH. In summary, repeated evaluations-including two liver biopsies and a year-long clinical follow-up-confirmed the diagnosis of AIH. This case underscores the importance of considering AIH in patients who initially present with acute hepatitis with prominent cholestatic features, even when the early clinical picture is atypical.

Indexed as

CholestasisHepatitis, AutoimmuneAcute DiseaseAntibodies, AntinuclearBiopsyChemical and Drug Induced Liver InjuryDiagnosis, DifferentialHumansImmunoglobulin GLiverMaleMiddle AgedAntibodies, AntinuclearImmunoglobulin Gacute cholestatic hepatitisautoimmune hepatitisazathioprinedrug-induced liver injuryglucocorticoidimmunoglobulin G

Identifiers

PMID42253964
PMCPMC13233668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.